- CA$27.70m
- CA$25.12m
- CA$11.36m
- 76
- 35
- 46
- 51
2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 42.8 | 32.9 | 26.5 | 23.7 | 11.4 |
Cost of Revenue | |||||
Gross Profit | 13.6 | 8.85 | 7.17 | 6.29 | 4.43 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Operating Interest Expense / Income | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 43.9 | 37.9 | 31.3 | 30.7 | 12.9 |
Operating Profit | -1.1 | -5.02 | -4.83 | -6.96 | -1.58 |
Net Income Before Taxes | -1.1 | -5.02 | -4.83 | -6.96 | -1.58 |
Provision for Income Taxes | |||||
Net Income After Taxes | -1.99 | -4.44 | -4.13 | -6.93 | -1.58 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -1.99 | -4.44 | -4.13 | -6.93 | -6.51 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -1.99 | -4.44 | -4.13 | -6.93 | -6.51 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.013 | -0.043 | -0.041 | -0.063 | -0.011 |